The role of dendritic cells in alphaherpesvirus infections: Archetypes and paradigms

Reviews in Medical Virology

Volumn 19, Issue 6, 2009, Pages 338-358

  Van De Walle, Gerlinde R ^a   Cox, Eric ^a   Nauwynck, Hans ^a   Favoreel, Herman W ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL2 CHEMOKINE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LECTIN; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CELL FUNCTION; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL SUBPOPULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; EQUINE HERPES VIRUS; HERPES VIRUS; HUMAN; INNATE IMMUNITY; MYELOID PROGENITOR CELL; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; SPECIES DIFFERENCE; T LYMPHOCYTE ACTIVATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION;

ALPHAHERPESVIRINAE; ANIMALS; DENDRITIC CELLS; HERPESVIRIDAE INFECTIONS; HUMANS; MODELS, BIOLOGICAL;

EID: 70449338978     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.628     Document Type: Review

References (214)

1. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106(3): 259-262.
2. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5(12): 1219-1226.
3. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17-58. (Pubitemid 47413194)
4. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol 2007; 19(1): 48-55. (Pubitemid 46498749)
5. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
6. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008; 26: 293-316. (Pubitemid 351600378)
7. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194(6): 863-869. (Pubitemid 32983021)
8. Granucci F, Zanoni I, Ricciardi-Castagnoli P. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell Mol Life Sci 2008; 65(11): 1683-1697.
9. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25: 381-418.
10. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106(3): 259-262.
11. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194(6): 863-869. (Pubitemid 32983021)
12. Cao W, Liu YJ. Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 2007; 19(1): 24-30. (Pubitemid 46073695)
13. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008; 19(1): 3-19.
14. Lund JM, Linehan MM, Iijima N, Iwasaki A. Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 2006; 177(11): 7510-7514. (Pubitemid 44846264)
15. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006; 312(5775): 879-882. (Pubitemid 43727313)
16. Pollara G, Jones M, Handley ME, et al. Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J Immunol 2004; 173(6): 4108-4119. (Pubitemid 39280776)
17. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006; 107(7): 2613-2618.
18. Katze MG, He Y, Gale M, Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2(9): 675-687.
19. Liu K, Victora GD, Schwickert TA, et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009; 324(5925): 392-397.
20. Merad M, Collin M, Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol 2007; 28(8): 353-359. (Pubitemid 47077925)
21. Rathinam C, Flavell RA. The hematopoiesis paradigm: clarity or ambiguity? Blood 2008; 112(9): 3534-3535.
22. Sathe P, Shortman K. The steady-state development of splenic dendritic cells. Mucosal Immunol 2008; 1(6): 425-431.
23. Merad M, Manz MG. Dendritic cell homeostasis. Blood 2009; 113(15): 3418-3427.
24. Sathe P, Shortman K. The steady-state development of splenic dendritic cells. Mucosal Immunol 2008; 1(6): 425-431.
25. Nagai Y, Garrett KP, Ohta S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006; 24(6): 801-812. (Pubitemid 43867369)
26. Corcoran L, Ferrero I, Vremec D, et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J Immunol 2003; 170(10): 4926-4932. (Pubitemid 36554721)
27. Sathe P, Shortman K. The steady-state development of splenic dendritic cells. Mucosal Immunol 2008; 1(6): 425-431.
28. Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol 2005; 25(6): 551-572. (Pubitemid 43011747)
29. Gouwy M, Struyf S, Proost P, Van DJ. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005; 16(6): 561-580.
30. Lalani AS, Barrett JW, McFadden G. Modulating chemokines: more lessons from viruses. Immunol Today 2000; 21(2): 100-106. (Pubitemid 30069624)
31. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003; 3(1): 36-50. (Pubitemid 37328698)
32. Seet BT, McFadden G. Viral chemokine-binding proteins. J Leukoc Biol 2002; 72(1): 24-34.
33. Van de Walle GR, Jarosinski KW, Osterrieder N. Alphaherpesviruses and chemokines: pas-de-deux not yet brought to perfection. J Virol 2008; 82(13): 6090-6097. (Pubitemid 351875091)
34. Pollara G, Kwan A, Newton PJ, Handley ME, Chain BM, Katz DR. Dendritic cells in viral pathogenesis: protective or defective? Int J Exp Pathol 2005; 86(4): 187-204.
35. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998; 188(2): 373-386. (Pubitemid 28357765)
36. McWilliam AS, Nelson D, Thomas JA, Holt PG. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 1994; 179(4): 1331-1336. (Pubitemid 24091791)
37. McWilliam AS, Marsh AM, Holt PG. Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J Virol 1997; 71(1): 226-236.
38. Sato A, Iwasaki A. Induction of antiviral immunity requires toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci USA 2004; 101(46): 16274-16279. (Pubitemid 39552835)
39. Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002; 169(12): 6673-6676. (Pubitemid 36899249)
40. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006; 107(7): 2613-2618.
41. Sallusto F, Palermo B, Lenig D, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999; 29(5): 1617-1625. (Pubitemid 29224467)
42. Sallusto F, Palermo B, Lenig D, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999; 29(5): 1617-1625. (Pubitemid 29224467)
43. Randolph GJ. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 2001; 13(5): 267-274.
44. Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999; 17: 739-779. (Pubitemid 29241139)
45. Gelin C, Sloma I, Charron D, Mooney N. Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. J Leukoc Biol 2009; 85(2): 215-224.
46. Merad M, Manz MG. Dendritic cell homeostasis. Blood 2009; 113(15): 3418-3427.
47. van Helden SF, van Leeuwen FN, Figdor CG. Human and murine model cell lines for dendritic cell biology evaluated. Immunol Lett 2008; 117(2): 191-197.
48. Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, et al. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 2005; 86(5): 323-334. (Pubitemid 41413627)
49. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
50. Beutler B, Rehli M. Evolution of the TIR, tolls and TLRs: functional inferences from computational biology. Curr Top Microbiol Immunol 2002; 270: 1-21. (Pubitemid 35448150)
51. Hochrein H, O'Keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum Immunol 2002; 63(12): 1103-1110. (Pubitemid 36025984)
52. Mazzoni A, Segal DM. Controlling the toll road to dendritic cell polarization. J Leukoc Biol 2004; 75(5): 721-730. (Pubitemid 38580050)
53. Reis e Sousa. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004; 16(1): 27-34.
54. Dakic A, Shao QX, D'Amico A, et al. Development of the dendritic cell system during mouse ontogeny. J Immunol 2004; 172(2): 1018-1027. (Pubitemid 38113761)
55. Kronin V, Vremec D, Winkel K, et al. Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int Immunol 1997; 9(7): 1061-1064. (Pubitemid 27277751)
56. Hochrein H, O'Keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum Immunol 2002; 63(12): 1103-1110. (Pubitemid 36025984)
57. Mazzoni A, Segal DM. Controlling the toll road to dendritic cell polarization. J Leukoc Biol 2004; 75(5): 721-730. (Pubitemid 38580050)
58. Reis e Sousa. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004; 16(1): 27-34.
59. Hochrein H, Wagner H. Of men, mice and pigs: looking at their plasmacytoid dendritic cells [corrected]. Immunology 2004; 112(1): 26-27. (Pubitemid 38609818)
60. Balfour BM, Drexhage HA, Kamperdijk EW, Hoefsmit EC. Antigen-presenting cells, including Langerhans cells, veiled cells and interdigitating cells. Ciba Found Symp 1981; 84: 281-301.
61. Drexhage HA, Mullink H, de GJ, Clarke J, Balfour BM. A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res 1979; 202(3): 407-430. (Pubitemid 10107072)
62. Summerfield A, McCullough KC. The porcine dendritic cell family. Dev Comp Immunol 2009; 33(3): 299-309.
63. Guzylack-Piriou L, Balmelli C, McCullough KC, Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 2004; 112(1): 28-37. (Pubitemid 38609819)
64. Ito T, Liu YJ, Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 2005; 81(3): 188-196. (Pubitemid 41364483)
65. Guzylack-Piriou L, Balmelli C, McCullough KC, Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 2004; 112(1): 28-37. (Pubitemid 38609819)
66. Guzylack-Piriou L, Piersma S, McCullough K, Summerfield A. Role of natural interferonproducing cells and T lymphocytes in porcine monocyte-derived dendritic cell maturation. Immunology 2006; 118(1): 78-87.
67. Siedek EM, Edington N, Hamblin A. Equine dendritic cell infection with equid herpesvirus type 1 reduces their ability to support mitogenic T cell proliferation. Biochem Soc Trans 1997; 25(2): 283S. (Pubitemid 27261043)
68. Hammond SA, Horohov D, Montelaro RC. Functional characterization of equine dendritic cells propagated ex vivo using recombinant human GM-CSF and recombinant equine IL-4. Vet Immunol Immunopathol 1999; 71(3-4): 197-214. (Pubitemid 29528239)
69. Mauel S, Steinbach F, Ludwig H. Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice. Immunology 2006; 117(4): 463-473.
70. Renjifo X, Howard C, Kerkhofs P, et al. Purification and characterization of bovine dendritic cells from peripheral blood. Vet Immunol Immunopathol 1997; 60(1-2): 77-88. (Pubitemid 28034285)
71. Emery DL, MacHugh ND, Ellis JA. The properties and functional activity of non-lymphoid cells from bovine afferent (peripheral) lymph. Immunology 1987; 62(2): 177-183.
72. Howard CJ, Brooke GP, Werling D, et al. Dendritic cells in cattle: phenotype and function. Vet Immunol Immunopathol 1999; 72(1-2): 119-124.
73. Pascale F, Contreras V, Bonneau M, et al. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 2008; 180(9): 5963-5972.
74. Schwartz-Cornil I, Epardaud M, Bonneau M. Cervical duct cannulation in sheep for collection of afferent lymph dendritic cells from head tissues. Nat Protoc 2006; 1(2): 874-879.
75. Pascale F, Contreras V, Bonneau M, et al. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 2008; 180(9): 5963-5972.
76. Perez TA, Millan Aldaco DA. Ia antigens are expressed on ATPase-positive dendritic cells in chicken epidermis. J Anat 1994; 184(Pt 3): 591-596.
77. Gallego M, Del CE, Zapata A, Bascuas JA. Ultrastructural identification of the splenic follicular dendritic cells in the chicken. Anat Rec 1995; 242(2): 220-224.
78. Gallego M, Del CE, Bascuas JA. Antigen-binding cells in the cecal tonsil and Peyer's patches of the chicken after bovine serum albumin administration. Poult Sci 1995; 74(3): 472-479.
79. Gallego M, Del CE, Lopez-Bernad F, Bascuas JA. Identification of avian dendritic cells in the spleen using a monoclonal antibody specific for chicken follicular dendritic cells. Anat Rec 1997; 249(1): 81-85. (Pubitemid 27391422)
80. Pellett PaRB. Herpesviridae. Fields Virology, 5th edn, Lippincott, Wilkinson and Wilkins: Philadelphia; 2007, 2479-2499. Ref Type: Serial (Book, Monograph)
81. Ehlers B, Kuchler J, Yasmum N, et al. Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus. J Virol 2007; 81(15): 8091-8100. (Pubitemid 47101495)
82. Becker Y. Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells-a review. Virus Genes 2003; 26(2): 119-130. (Pubitemid 36649155)
83. Sprecher E, Becker Y. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch Virol 1989; 107(3-4): 191-205. (Pubitemid 19272083)
84. Allan RS, Waithman J, Bedoui S, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25(1): 153-162. (Pubitemid 44066832)
85. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007; 7(7): 543-555. (Pubitemid 46987783)
86. Allan RS, Waithman J, Bedoui S, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25(1): 153-162. (Pubitemid 44066832)
87. Randolph GJ. Migratory dendritic cells: sometimes simply ferries? Immunity 2006; 25(1): 15-18.
88. Bedoui S, Whitney PG, Waithman J, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009; 10(5): 488-495.
89. Zhao X, Deak E, Soderberg K, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003; 197(2): 153-162. (Pubitemid 36152310)
90. Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1. J Immunol 2009; 182(1): 283-292.
91. Iijima N, Linehan MM, Zamora M, et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med 2008; 205(13): 3041-3052.
92. Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 2006; 80(8): 3985-3993.
93. Kassim SH, Rajasagi NK, Ritz BW, et al. Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1. J Virol 2009; 83(7): 3175-3186.
94. Lee HK, Zamora M, Linehan MM, et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med 2009; 206(2): 359-370.
95. Yoneyama H, Matsuno K, Toda E, et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005; 202(3): 425-435. (Pubitemid 41126960)
96. Lund JM, Linehan MM, Iijima N, Iwasaki A. Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 2006; 177(11): 7510-7514. (Pubitemid 44846264)
97. Kittan NA, Bergua A, Haupt S, et al. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virus-associated acute retinal necrosis. J Immunol 2007; 179(6): 4219-4230.
98. Yoneyama H, Matsuno K, Toda E, et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005; 202(3): 425-435. (Pubitemid 41126960)
99. Barr DP, Belz GT, Reading PC, et al. A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur J Immunol 2007; 37(5): 1334-1342.
100. Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr 2005; 146(3): 423-425. (Pubitemid 40341757)
101. Donaghy H, Bosnjak L, Harman AN, et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol 2009; 83(4): 1952-1961.
102. Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000; 192(2): 219-226. (Pubitemid 30470304)
103. Kawamura K, Kadowaki N, Suzuki R, et al. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity. J Immunother 2006; 29(2): 165-174. (Pubitemid 43756092)
104. Cantin E, Tanamachi B, Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 1999; 73(4): 3418-3423. (Pubitemid 29135735)
105. Liu T, Khanna KM, Carriere BN, Hendricks RL. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 2001; 75(22): 11178-11184. (Pubitemid 33031584)
106. Decman V, Kinchington PR, Harvey SA, Hendricks RL. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol 2005; 79(16): 10339-10347. (Pubitemid 41098574)
107. Mott KR, Underhill D, Wechsler SL, Ghiasi H. Lymphoid- related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency. J Virol 2008; 82(20): 9870-9879.
108. Mott KR, Ghiasi H. Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. Clin Vaccine Immunol 2008; 15(12): 1859-1867.
109. Mott KR, Ghiasi H. Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. Clin Vaccine Immunol 2008; 15(12): 1859-1867.
110. Latz E, Schoenemeyer A, Visintin A, et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5(2): 190-198. (Pubitemid 38208361)
111. Gohda J, Matsumura T, Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol 2004; 173(5): 2913-2937. (Pubitemid 39141993)
112. Honda K, Yanai H, Mizutani T, et al. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 2004; 101(43): 15416-15421. (Pubitemid 39441556)
113. Honda K, Ohba Y, Yanai H, et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005; 434(7036): 1035-1040. (Pubitemid 40586053)
114. Yang K, Puel A, Zhang S, et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and - lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005; 23(5): 465-478.
115. Kim TW, Staschke K, Bulek K, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 2007; 204(5): 1025-1036. (Pubitemid 46798147)
116. Honda K, Yanai H, Mizutani T, et al. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in toll-like receptor signaling. Proc Natl Acad Sci USA 2004; 101(43): 15416-15421. (Pubitemid 39441556)
117. Kawai T, Sato S, Ishii KJ, et al. Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5(10): 1061-1068. (Pubitemid 41057726)
118. Guiducci C, Ghirelli C, Marloie-Provost MA, et al. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med 2008; 205(2): 315-322. (Pubitemid 351281597)
119. Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 2002; 14(3): 373-379. (Pubitemid 34327981)
120. Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002; 14(1): 111-116. (Pubitemid 34085114)
121. Barchet W, Cella M, Odermatt B, sselin-Paturel C, Colonna M, Kalinke U. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 2002; 195(4): 507-516. (Pubitemid 34461303)
122. Colina R, Costa-Mattioli M, Dowling RJ, et al. Translational control of the innate immune response through IRF-7. Nature 2008; 452(7185): 323-328.
123. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198(3): 513-520. (Pubitemid 36976063)
124. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103(4): 1433-1437. (Pubitemid 38168659)
125. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004; 101(31): 11416-11421. (Pubitemid 39038361)
126. Hochrein H, Wagner H. Of men, mice and pigs: looking at their plasmacytoid dendritic cells [corrected]. Immunology 2004; 112(1): 26-27. (Pubitemid 38609818)
127. Mazzoni A, Segal DM. Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 2004; 75(5): 721-730. (Pubitemid 38580050)
128. Reis e Sousa. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 2004; 16(1): 27-34.
129. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306. (Pubitemid 40563171)
130. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8(8): 594-606.
131. Kurt-Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101(5): 1315-1320. (Pubitemid 38182686)
132. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 2005; 175(7): 4189-4193. (Pubitemid 41361951)
133. Kurt-Jones EA, Chan M, Zhou S, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101(5): 1315-1320. (Pubitemid 38182686)
134. Kurt-Jones EA, Belko J, Yu C, et al. The role of toll-like receptors in herpes simplex infection in neonates. J Infect Dis 2005; 191(5): 746-748. (Pubitemid 40271064)
135. Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 2006; 103(46): 17343-17348. (Pubitemid 44788971)
136. Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 2008; 181(12): 8604-8612.
137. Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 2006; 103(46): 17343-17348. (Pubitemid 44788971)
138. Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 2008; 181(12): 8604-8612.
139. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008; 21(1): 13-25. (Pubitemid 351160008)
140. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB. Does Toll-like receptor 3 play a biological role in virus infections? Virology 2004; 322(2): 231-238.
141. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008; 21(1): 13-25. (Pubitemid 351160008)
142. Jacquemont B, Roizman B. RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J Virol 1975; 15(4): 707-713.
143. Herbst-Kralovetz M, Pyles R. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006; 13(2): 37-41. (Pubitemid 44299019)
144. Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 2004; 190(10): 1841-1849.
145. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314(5797): 308-312.
146. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 defi- ciency in patients with herpes simplex encephalitis. Science 2007; 317(5844): 1522-1527.
147. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61(11): 1013-1021. (Pubitemid 35278723)
148. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005; 175(7): 4320-4330. (Pubitemid 41361966)
149. Prehaud C, Megret F, Lafage M, Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005; 79(20): 12893-12904. (Pubitemid 41433208)
150. Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 2006; 74(5): 824-831.
151. Nasu K, Itoh H, Yuge A, Nishida M, Narahara H. Human oviductal epithelial cells express Toll-like receptor 3 and respond to double-stranded RNA: Fallopian tube-specific mucosal immunity against viral infection. Hum Reprod 2007; 22(2): 356-361. (Pubitemid 46152553)
152. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004; 101(31): 11416-11421. (Pubitemid 39038361)
153. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004; 101(31): 11416-11421. (Pubitemid 39038361)
154. Ankel H, Westra DF, Welling-Wester S, Lebon P. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 1998; 251(2): 317-326. (Pubitemid 28535901)
155. Pollara G, Katz DR, Chain BM. LIGHTing up dendritic cell activation: immune regulation and viral exploitation. J Cell Physiol 2005; 205(2): 161-162. (Pubitemid 41428896)
156. Reske A, Pollara G, Krummenacher C, Katz DR, Chain BM. Glycoprotein-dependent and TLR2- independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J Immunol 2008; 180(11): 7525-7536.
157. de Jong MA, de WL, Bolmstedt A, van KY, Geijtenbeek TB. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J Gen Virol 2008; 89(Pt 10): 2398-2409.
158. Mikloska Z, Bosnjak L, Cunningham AL. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol 2001; 75(13): 5958-5964. (Pubitemid 32553126)
159. Muller DB, Raftery MJ, Kather A, Giese T, Schonrich G. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur J Immunol 2004; 34(4): 941-951. (Pubitemid 39255972)
160. Novak N, Peng WM. Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells. Clin Exp Immunol 2005; 142(3): 405-410. (Pubitemid 41719834)
161. Bosnjak L, Jones CA, Abendroth A, Cunningham AL. Dendritic cell biology in herpesvirus infections. Viral Immunol 2005; 18(3): 419-433.
162. Mikloska Z, Bosnjak L, Cunningham AL. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol 2001; 75(13): 5958-5964. (Pubitemid 32553126)
163. Mikloska Z, Bosnjak L, Cunningham AL. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol 2001; 75(13): 5958-5964. (Pubitemid 32553126)
164. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999; 29(10): 3245-3253. (Pubitemid 29484215)
165. Pollara G, Speidel K, Samady L, et al. Herpes simplex virus infection of
166. Jones CA, Fernandez M, Herc K, et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol 2003; 77(20): 11139-11149. (Pubitemid 37204303)
167. Luksch CR, Winqvist O, Ozaki ME, et al. Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. Proc Natl Acad Sci USA 1999; 96(6): 3023-3028. (Pubitemid 29148837)
168. Raftery MJ, Winau F, Kaufmann SH, Schaible UE, Schonrich G. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J Immunol 2006; 177(9): 6207-6214. (Pubitemid 44628839)
169. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22: 817-890. (Pubitemid 38680443)
170. Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol 2003; 170(3): 1430-1434. (Pubitemid 36139511)
171. Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003; 77(18): 10168-10171.
172. Raftery MJ, Winau F, Kaufmann SH, Schaible UE, Schonrich G. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J Immunol 2006; 177(9): 6207-6214. (Pubitemid 44628839)
173. Yuan W, Dasgupta A, Cresswell P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol 2006; 7(8): 835-842. (Pubitemid 44084090)
174. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999; 29(10): 3245-3253. (Pubitemid 29484215)
175. Samady L, Costigliola E, MacCormac L, et al. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy. J Virol 2003; 77(6): 3768-3776. (Pubitemid 36297295)
176. Jin H, Ma Y, Prabhakar BS, et al. The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection. J Virol 2009; 83(10): 4984-4994.
177. Jones CA, Fernandez M, Herc K, et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol 2003; 77(20): 11139-11149. (Pubitemid 37204303)
178. Muller DB, Raftery MJ, Kather A, Giese T, Schonrich G. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur J Immunol 2004; 34(4): 941-951. (Pubitemid 39255972)
179. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005; 174(4): 2220-2227. (Pubitemid 40223968)
180. Muller DB, Raftery MJ, Kather A, Giese T, Schonrich G. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur J Immunol 2004; 34(4): 941-951. (Pubitemid 39255972)
181. Aubert M, Blaho JA. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 1999; 73(4): 2803-2813. (Pubitemid 29135667)
182. Aubert M, O'Toole J, Blaho JA. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol 1999; 73(12): 10359-10370.
183. Kruse M, Rosorius O, Kratzer F, et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 2000; 74(15): 7127-7136. (Pubitemid 30470697)
184. Kummer M, Turza NM, Muhl-Zurbes P, et al. Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediateearly kinetics via the cellular proteasome. J Virol 2007; 81(12): 6326-6338. (Pubitemid 46878039)
185. Prechtel AT, Turza NM, Kobelt DJ, et al. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J Gen Virol 2005; 86(Pt 6): 1645-1657.
186. Theodoridis AA, Prechtel AT, Turza NM, Zenke M, Steinkasserer A. Infection of human dendritic cells with herpes simplex virus type 1 dramatically diminishes the mRNA levels of the prostaglandin E(2) receptors EP2 and EP4. Immunobiology 2007; 212(9-10): 827-838.
187. Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte- derived dendritic cells. Blood 2002; 100(4): 1354-1361.
188. Eisemann J, Muhl-Zurbes P, Steinkasserer A, Kummer M. Infection of mature dendritic cells with herpes simplex virus type 1 interferes with the interferon signaling pathway. Immunobiology 2007; 212(9-10): 877-886.
189. Abendroth A, Morrow G, Cunningham AL, Slobedman B. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J Virol 2001; 75(13): 6183-6192. (Pubitemid 32553149)
190. Morrow G, Slobedman B, Cunningham AL, Abendroth A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol 2003; 77(8): 4950-4959. (Pubitemid 36402843)
191. Morrow G, Slobedman B, Cunningham AL, Abendroth A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol 2003; 77(8): 4950-49599.
192. Abendroth A, Arvin A. Immune evasion mechanisms of varicella-zoster virus. Arch Virol Suppl 2001; (17): 99-107.
193. Siedek EM, Edington N, Hamblin A. Equine dendritic cell infection with equid herpesvirus type 1 reduces their ability to support mitogenic T cell proliferation. Biochem Soc Trans 1997; 25(2): 283S.
194. Palucka AK, Laupeze B, Aspord C, et al. Immunotherapy via dendritic cells. Adv Exp Med Biol 2005; 560: 105-114.
195. Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008; 29(3): 319-324.
196. Jenne L, Schuler G, Steinkasserer A. Viral vectors for dendritic cell-based immunotherapy. Trends Immunol 2001; 22(2): 102-107.
197. Jenne L, Steinkasserer A. DNA viruses and genetic modification of dendritic cells. Arch Immunol Ther Exp (Warsz) 2002; 50(4): 273-277.
198. Jenne L, Thumann P, Steinkasserer A. Interaction of large DNA viruses with dendritic cells. Immunobiology 2001; 204(5): 639-648.
199. Humrich J, Jenne L. Viral vectors for dendritic cell-based immunotherapy. Curr Top Microbiol Immunol 2003; 276: 241-259.
200. Jenne L, Thumann P, Steinkasserer A. Interaction of large DNA viruses with dendritic cells. Immunobiology 2001; 204(5): 639-648.
201. Spaete RR, Frenkel N. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 1982; 30(1): 295-304.
202. Spaete RR, Frenkel N. The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc Natl Acad Sci USA 1985; 82(3): 694-698.
203. Frenkel N, Singer O, Kwong AD. Minireview: the herpes simplex virus amplicon-a versatile defective virus vector. Gene Ther 1994; 1(Suppl 1): S40-S46.
204. Oehmig A, Fraefel C, Breakefield XO. Update on herpesvirus amplicon vectors. Mol Ther 2004; 10(4): 630-643.
205. Epstein AL. HSV-1-derived recombinant and amplicon vectors for preventive or therapeutic gene transfer: an overview. Gene Ther 2005; 12(Suppl 1): S153.
206. Santos K, Duke CM, Dewhurst S. Amplicons as vaccine vectors. Curr Gene Ther 2006; 6(3): 383-392.
207. Willis RA, Bowers WJ, Turner MJ, et al. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice. Hum Gene Ther 2001; 12(15): 1867-1879.
208. Nunez R, Fraefel C, Suter M, Nunez-Liman A, Liou HC, Ackerman M. Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors. Immunol Res 2004; 30(1): 105-124.
209. Gorantla S, Santos K, Meyer V, et al. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/ SCID mice and confer partial protection against HIV-1 challenge. J Virol 2005; 79(4): 2124-2132.
210. Santos K, Duke CM, Dewhurst S. Amplicons as vaccine vectors. Curr Gene Ther 2006; 6(3): 383-392.
211. Prieto J, Solera J, Tabares E. Development of new expression vector based on Pseudorabies virus amplicons: application to human insulin expression. Virus Res 2002; 89(1): 123-129.
212. Trapp S, von Einem J, Hofmann H, et al. Potential of equine herpesvirus 1 as a vector for immunization. J Virol 2005; 79(9): 5445-5454.
213. Rosas C, Van de Walle GR, Metzger SM, et al. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza. Vaccine 2008; 26(19): 2335-2343.
214. Rosas CT, Konig P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J Gen Virol 2007; 88(Pt 3): 748-757.